Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,156.00
-11.00 (-0.51%)
Aug 28, 2026, 4:59 PM CET
Genmab Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 128,716 | 124,862 | 94,810 | 140,770 | 192,229 | 172,063 | |
Market Cap Growth | 31.87% | 31.70% | -32.65% | -26.77% | 11.72% | 6.80% |
Enterprise Value | 153,342 | 104,053 | 78,479 | 114,038 | 169,070 | 153,757 |
Last Close Price | 2156.00 | 2027.00 | 1492.50 | 2155.00 | 2941.00 | 2630.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.04 | 20.38 | 11.62 | 33.03 | 35.26 | 58.19 |
Forward PE | 22.87 | 20.23 | 17.44 | 29.87 | 39.46 | 56.53 |
PS Ratio | 4.76 | 5.28 | 4.22 | 8.72 | 13.25 | 20.44 |
PB Ratio | 3.30 | 3.36 | 2.56 | 4.45 | 7.05 | 7.75 |
P/TBV Ratio | - | - | 4.31 | 4.46 | 7.08 | 7.84 |
P/FCF Ratio | 22.63 | 17.08 | 11.98 | 20.47 | 53.47 | 87.08 |
P/OCF Ratio | 22.08 | 16.55 | 11.69 | 19.46 | 49.14 | 77.23 |
PEG Ratio | 1.12 | 3.70 | 0.92 | 1.96 | 1.64 | 2.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.67 | 4.40 | 3.49 | 7.06 | 11.66 | 18.27 |
EV/EBITDA Ratio | 16.81 | 12.68 | 10.36 | 21.05 | 25.79 | 48.86 |
EV/EBIT Ratio | 17.57 | 13.09 | 10.73 | 21.87 | 26.98 | 52.07 |
EV/FCF Ratio | 26.96 | 14.24 | 9.91 | 16.59 | 47.03 | 77.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.89 | 0.93 | 0.03 | 0.02 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 3.78 | 4.15 | 0.13 | 0.14 | 0.09 | 0.14 |
Debt / FCF Ratio | 6.07 | 4.72 | 0.13 | 0.11 | 0.17 | 0.22 |
Net Debt / Equity Ratio | 0.63 | 0.64 | -0.55 | -0.87 | -0.80 | -0.85 |
Net Debt / EBITDA Ratio | 2.73 | 2.88 | -2.67 | -5.06 | -3.31 | -6.01 |
Net Debt / FCF Ratio | 4.33 | 3.23 | -2.56 | -3.98 | -6.04 | -9.57 |
Asset Turnover | 0.44 | 0.39 | 0.54 | 0.49 | 0.53 | 0.37 |
Inventory Turnover | 18.58 | 17.63 | 16.82 | - | - | - |
Quick Ratio | 2.44 | 2.01 | 5.23 | 13.33 | 15.48 | 14.50 |
Current Ratio | 2.46 | 2.02 | 5.24 | 13.35 | 15.48 | 14.50 |
Return on Equity (ROE) | 14.00% | 17.54% | 23.07% | 14.46% | 22.04% | 14.31% |
Return on Assets (ROA) | 8.79% | 8.10% | 10.89% | 9.96% | 14.31% | 8.06% |
Return on Invested Capital (ROIC) | 12.07% | 16.82% | 58.66% | 83.50% | 108.72% | 64.65% |
Return on Capital Employed (ROCE) | 11.70% | 10.90% | 17.90% | 15.90% | 22.10% | 12.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.01% | 4.91% | 8.61% | 3.03% | 2.84% | 1.72% |
FCF Yield | 4.42% | 5.85% | 8.35% | 4.88% | 1.87% | 1.15% |
Buyback Yield / Dilution | 1.73% | 3.04% | 1.88% | 0.17% | 0.06% | -0.24% |